Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Topical Use of a Silibin-based Cream, Difinsa53™, to Prevent Radiation Dermatitis in Patients With Breast Cancer: A Prospective Study

NCT02534129 is registered in ClinicalTrials.gov with ProTechSure Scientific, Inc. as lead sponsor.

NCT NCT02534129
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02534129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Topical Use of a Silibin-based Cream, Difinsa53™, to Prevent Radiation Dermatitis in Patients With Breast Cancer: A Prospective Study
Lead sponsor
ProTechSure Scientific, Inc.
Phase
Phase 1/2
Overall status
Terminated
Start date
August 31, 2015
Completion date
March 31, 2016
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

radiodermatitis